Skip to main content

125/DPI (Estropipate 1.5 mg)

Pill with imprint 125/DPI has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.

Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 125/DPI


1.5 mg
Prescription only
Drug Class
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00364-2601 (Discontinued)

Get help with Imprint Code FAQs.

Related Images for "125/DPI"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.